Media Summary: Whether surgical axillary staging can be safely Marjolein Smidt, MD, PhD, Maastricht University Medical Center, Maastricht, Netherlands, discusses 5-year results from the BOOG ... Although completion lymph-node dissection has been recommended in patients with melanoma and

Omitting Sentinel Node Biopsy In Small Breast Cancers Nejm - Detailed Analysis & Overview

Whether surgical axillary staging can be safely Marjolein Smidt, MD, PhD, Maastricht University Medical Center, Maastricht, Netherlands, discusses 5-year results from the BOOG ... Although completion lymph-node dissection has been recommended in patients with melanoma and [Oncoinfo – Istantanee di Oncologia: seguici su Skipping sentinel lymph node biopsy (SLNB) in patients ... Walter Weber, MD, Basel University Hospital, Basel, Switzerland, comments on the role of the Cicero Urban, MD, PhD, Hospital Nossa Senhora das Gracas, Curitiba, Brazil, discusses the evolving approach to axillary surgery ...

... Program and Cancer Surgery Standards Program. This episode highlights Prof Marjolein Smidt speaks to ecancer about

Photo Gallery

Omitting Sentinel-Node Biopsy in Small Breast Cancers | NEJM
Dr. Glaucomflecken Explains: Omitting Sentinel-Node Biopsy in Small Breast Cancers (INSEMA)
What are the new ASCO Guidelines 2025: Sentinel Lymph Node Biopsy for Breast Cancer?
Omitting sentinel node biopsy in early breast cancer: 5-year BOOG 2013-08 data
Omitting Axillary Dissection in Breast Cancer | NEJM
Sentinel Lymph Node Biopsy for Breast Cancer: Who Needs It and When Can It Be Skipped?
Dissection or Observation in Melanoma
INSEMA trial for breast cancer - not everyone needs lymph nodes removed #women breastcancersurgery
Sentinel Node Biopsy for Breast Cancer (Lymph Node Removal) | What Should You Expect?
Sentinel Lymph Node Biopsy in Breast Cancer: Purpose, Benefits & Risks Explained
BOOG 2013-08: could sentinel lymph node biopsy be safely omitted in early-stage breast cancer?
Why Sentinel Node Biopsy Matters in Breast Cancer Surgery #breastcancer #biopsy
Sponsored
Sponsored
View Detailed Profile
Omitting Sentinel-Node Biopsy in Small Breast Cancers | NEJM

Omitting Sentinel-Node Biopsy in Small Breast Cancers | NEJM

Whether surgical axillary staging can be

Dr. Glaucomflecken Explains: Omitting Sentinel-Node Biopsy in Small Breast Cancers (INSEMA)

Dr. Glaucomflecken Explains: Omitting Sentinel-Node Biopsy in Small Breast Cancers (INSEMA)

Whether surgical axillary staging can be safely

Sponsored
What are the new ASCO Guidelines 2025: Sentinel Lymph Node Biopsy for Breast Cancer?

What are the new ASCO Guidelines 2025: Sentinel Lymph Node Biopsy for Breast Cancer?

FULL ARTICLE: ...

Omitting sentinel node biopsy in early breast cancer: 5-year BOOG 2013-08 data

Omitting sentinel node biopsy in early breast cancer: 5-year BOOG 2013-08 data

Marjolein Smidt, MD, PhD, Maastricht University Medical Center, Maastricht, Netherlands, discusses 5-year results from the BOOG ...

Omitting Axillary Dissection in Breast Cancer | NEJM

Omitting Axillary Dissection in Breast Cancer | NEJM

Previous trials have shown that

Sponsored
Sentinel Lymph Node Biopsy for Breast Cancer: Who Needs It and When Can It Be Skipped?

Sentinel Lymph Node Biopsy for Breast Cancer: Who Needs It and When Can It Be Skipped?

Do you really need a

Dissection or Observation in Melanoma

Dissection or Observation in Melanoma

Although completion lymph-node dissection has been recommended in patients with melanoma and

INSEMA trial for breast cancer - not everyone needs lymph nodes removed #women breastcancersurgery

INSEMA trial for breast cancer - not everyone needs lymph nodes removed #women breastcancersurgery

... invasive

Sentinel Node Biopsy for Breast Cancer (Lymph Node Removal) | What Should You Expect?

Sentinel Node Biopsy for Breast Cancer (Lymph Node Removal) | What Should You Expect?

What is a

Sentinel Lymph Node Biopsy in Breast Cancer: Purpose, Benefits & Risks Explained

Sentinel Lymph Node Biopsy in Breast Cancer: Purpose, Benefits & Risks Explained

Is

BOOG 2013-08: could sentinel lymph node biopsy be safely omitted in early-stage breast cancer?

BOOG 2013-08: could sentinel lymph node biopsy be safely omitted in early-stage breast cancer?

[Oncoinfo – Istantanee di Oncologia: seguici su http://oncoinfo.it] Skipping sentinel lymph node biopsy (SLNB) in patients ...

Why Sentinel Node Biopsy Matters in Breast Cancer Surgery #breastcancer #biopsy

Why Sentinel Node Biopsy Matters in Breast Cancer Surgery #breastcancer #biopsy

Sentinel Lymph

Selecting patients with breast cancer who can avoid axillary surgery

Selecting patients with breast cancer who can avoid axillary surgery

Walter Weber, MD, Basel University Hospital, Basel, Switzerland, comments on the role of the

De-escalation of axillary surgery in breast cancer

De-escalation of axillary surgery in breast cancer

Cicero Urban, MD, PhD, Hospital Nossa Senhora das Gracas, Curitiba, Brazil, discusses the evolving approach to axillary surgery ...

What is a Sentinel Lymph Node Biopsy, and why do I need it?  Dr Tasha’s Expert Insight

What is a Sentinel Lymph Node Biopsy, and why do I need it? Dr Tasha’s Expert Insight

Sentinel Lymph

Operative Standards for Cancer Surgery Series: Sentinel Lymph Node Biopsy for Breast Cancer

Operative Standards for Cancer Surgery Series: Sentinel Lymph Node Biopsy for Breast Cancer

... Program and Cancer Surgery Standards Program. This episode highlights

Sentinel Lymph Node Biopsy | Procedure & Side-effects | Visual Explanation

Sentinel Lymph Node Biopsy | Procedure & Side-effects | Visual Explanation

A

Sentinel Lymph Node Biopsy Indicators With Breast Cancer

Sentinel Lymph Node Biopsy Indicators With Breast Cancer

Dr. Harness explains when a

What can you tell about sentinel node biopsy? - Dr. Nanda Rajaneesh

What can you tell about sentinel node biopsy? - Dr. Nanda Rajaneesh

So for the benefit of doing

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative breast cancer af...

Omitting sentinel lymph node biopsy is safe in early HR-positive, HER2-negative breast cancer af...

Prof Marjolein Smidt speaks to ecancer about